Q Biomed Inc’s Metastron First Commercial Sale Commences Following Transfer of Intellectual Property and New Manufacturing Site Establishment

Investing, Q Biomed Inc /

Track all markets on TradingView Q Biomed Inc (QBIO) announced that the first commercial sale of Metastron™ is set to happen following the successful transfer or assignment of all intellectual property, material sales and distribution data, technical transfer, and the establishment of new manufacturing sites under the appropriate regulatory filings required. This development marks a […]

Q Biomed Inc’s Metastron First Commercial Sale Commences Following Transfer of Intellectual Property and New Manufacturing Site Establishment Read More »

Q BioMed Inc.’s Q1 2023 net loss increases while exploring licensing and acquisitions

Investing, Q Biomed Inc /

Track all markets on TradingView Q BioMed Inc. (QBMG), a biomedical acceleration and development company, released its financial report for Q1 2023, revealing a net loss of $721,612 that is larger than the net loss of $2,288,623 observed during the same period last year. Despite the increased net loss, the company continues to focus on

Q BioMed Inc.’s Q1 2023 net loss increases while exploring licensing and acquisitions Read More »

Q Biomed Inc. Reports Unaudited Financial Statements for the Quarter Ended February 2023

Investing, Q Biomed Inc /

Track all markets on TradingView Q Biomed Inc. (QBIO), a biotechnology company focused on addressing unmet medical needs through innovations and acquisitions in healthcare, has recently submitted its unaudited financial statements for the quarter ended February 28, 2023. The company acknowledges that the financial statements included in the Form 10-Q have not been independently reviewed

Q Biomed Inc. Reports Unaudited Financial Statements for the Quarter Ended February 2023 Read More »

Enerpac Tool Group Corp’s Core Sales Increase by 4% Due to Pricing Actions Following ASCEND Transformation Program

Enerpac Tool Group Corp, Investing /

Track all markets on TradingView Enerpac Tool Group Corp (EPAC), a global provider of branded hydraulic and mechanical tools and services, has reported an increase in core sales as a result of pricing actions undertaken during the company’s ASCEND transformation program. According to the company’s SEC report, for the quarter ending May 31, 2023, EPAC

Enerpac Tool Group Corp’s Core Sales Increase by 4% Due to Pricing Actions Following ASCEND Transformation Program Read More »

Enerpac Tool Group Corp Reports Improved Q3 Earnings and Continues ASCEND Transformation Program

Enerpac Tool Group Corp, Investing /

Track all markets on TradingView Enerpac Tool Group Corp (EPAC) recently released its SEC report for the three and nine months ended May 31, 2023, revealing improved earnings and progress on their ASCEND transformation program. The company’s earnings per share from continuing operations increased from $0.07 in Q3 2022 to $0.30 in Q3 2023, and

Enerpac Tool Group Corp Reports Improved Q3 Earnings and Continues ASCEND Transformation Program Read More »

Enerpac Tool Group’s ASCEND Transformation Program Aims to Drive Accelerated Earnings Growth and Efficiency, Estimating Annual Operating Profit of $50 to $60 Million

Enerpac Tool Group Corp, Investing /

Track all markets on TradingView Enerpac Tool Group Corp (EPAC), a leading manufacturer and distributor of a diverse range of industrial tools and services, has recently announced its new ASCEND Transformation Program. The program, which was launched in March 2022, aims to drive accelerated earnings growth and efficiency across the business. By fully implementing the

Enerpac Tool Group’s ASCEND Transformation Program Aims to Drive Accelerated Earnings Growth and Efficiency, Estimating Annual Operating Profit of $50 to $60 Million Read More »

Enerpac Tool Group Corp. Achieves Strong Q3 Performance, with Net Sales of $156.25 Million

Enerpac Tool Group Corp, Investing /

Track all markets on TradingView Enerpac Tool Group Corp (EPAC), a global leader in industrial tools and services, has reported strong financial results for the third quarter of fiscal 2023, driven by solid growth in both product and service sales. The company’s net sales reached $156.25 million during the period, reflecting a 2.86% increase compared

Enerpac Tool Group Corp. Achieves Strong Q3 Performance, with Net Sales of $156.25 Million Read More »

Enerpac Tool Group Corp Reports Increased Q3 Net Sales in 2023 SEC Filing

Enerpac Tool Group Corp, Investing /

Track all markets on TradingView Enerpac Tool Group Corp (NYSE: EPAC), a global leader in industrial tools and services, has reported an increase in net sales for the third quarter of 2023, as stated in a recent SEC filing. The filing shows the company’s growth and stability during a challenging economic landscape, highlighting its resilience

Enerpac Tool Group Corp Reports Increased Q3 Net Sales in 2023 SEC Filing Read More »

Nocturne Acquisition Corp Faces Increased Costs and Time Constraints Amid SEC Proposed Rules for SPACs

Investing, Nocturne Acquisition Corp /

Track all markets on TradingView Nocturne Acquisition Corp (ticker: MBTC), a special purpose acquisition company (SPAC), faces increased costs and time constraints as the Securities and Exchange Commission (SEC) recently issued proposed rules related to disclosure, financial statement requirements, and potential liability amongst others for SPACs. The company is currently paying its sponsor a monthly

Nocturne Acquisition Corp Faces Increased Costs and Time Constraints Amid SEC Proposed Rules for SPACs Read More »

Nocturne Acquisition Corp Enters Merger Agreement with Cognos Therapeutics, Plans to Become Cognos Therapeutics Holdings, Inc.

Investing, Nocturne Acquisition Corp /

Track all markets on TradingView Nocturne Acquisition Corp (MBTC) has entered into a merger agreement and plans to domesticate as a Delaware corporation, renaming itself Cognos Therapeutics Holdings, Inc. The company recently reported its financial activities and subsequent events from their initial public offering (IPO) in April 2021. Their primary objective is to execute a

Nocturne Acquisition Corp Enters Merger Agreement with Cognos Therapeutics, Plans to Become Cognos Therapeutics Holdings, Inc. Read More »